Skip to main content

memo - Magazine of European Medical Oncology

Ausgabe 2/2023

Inhalt (13 Artikel)

ESMO 2022

  • editorial

Rupert Bartsch

Colorectal cancer special, part 2

  • editorial

Armin Gerger

ESMO 2022 personal non-small lung cancer (NSCLC) highlights

  • short review

Lena Horvath, Georg Pall

ESMO 2022: spotlight on new emerging treatment options in central nervous system tumors

  • Open Access
  • short review

Maximilian J. Mair, Anna S. Berghoff

ESMO update: upper gastrointestinal cancer

  • Open Access
  • short review

Elisabeth S. Bergen, Aysegül Ihan-Mutlu

Immunotherapy for metastatic melanoma—from little benefit to first-line treatment

  • Open Access
  • short review

Christiane G. Mutz-Rabl, Peter Koelblinger, Lukas Koch

Lessons learned in adjuvant colorectal cancer

  • Open Access
  • short review

Theresa Schmalfuss, Hossein Taghizadeh

Molecular pathology of colorectal cancer

  • Open Access
  • review

Petar Noack, Rupert Langer

Excellent response of a disseminated SMARCA4-deficient thoracic sarcomatoid tumor to immunochemotherapy—a case report

  • case report

Clemens Petrasch, Simon Udovica, Frédéric Witte, Bernadette Liegl-Atzwanger, Wolfgang Pokieser, Siroos Mirzaei, Wolfgang Hilbe, Andrea Kaufmann-Keck

Spectrum of renal involvement in MGRS patients: a 6-year study

  • original report

Poornima Tadkal, Vishwanath Siddini, V. Mahesha, Sudarshan Ballal, Rohan Augustine, Kishore Babu, Mallikarjun Kalashetty

Position paper on CDK4/6 inhibitors in early breast cancer

  • Open Access
  • position paper

Michael Gnant, Christian F. Singer, Gabriel Rinnerthaler, Georg Pfeiler, Daniel Egle, Marija Balic, Rupert Bartsch